Razzouk Louai, Aggarwal Saurabh, Gorgani Farzan, Babaev Anvar
New York University, Department of Medicine, Division of Cardiology, New York, NY 10069, USA.
Ann Vasc Surg. 2013 May;27(4):510-24. doi: 10.1016/j.avsg.2012.09.005. Epub 2013 Mar 25.
As the number of endovascular peripheral arterial interventions is increasing nationwide, so is the rate of observed in-stent restenosis, specifically in the superficial femoral artery. A paucity of literature is available regarding the pathophysiology, risk factors, and therapies associated with in-stent restenosis of the superficial femoral artery. This article summarizes the accumulated knowledge on these topics and sheds some light on the prospects for future therapies.
随着全国范围内血管内周围动脉介入治疗数量的增加，观察到的支架内再狭窄发生率也在上升，尤其是在股浅动脉。关于股浅动脉支架内再狭窄的病理生理学、危险因素和治疗方法的文献较少。本文总结了这些主题的积累知识，并对未来治疗的前景提供了一些见解。
